Cargando…

Intraoperative Hemoadsorption (Cytosorb™) during Open Thoracoabdominal Aortic Repair: A Pilot Randomized Controlled Trial

Background: The efficacy of cytokine adsorption in controlling the early inflammation cascade after open thoracoabdominal aortic (TAAA) repair has not been investigated. The aim of this pilot randomized controlled trial was to assess the feasibility and effect of perioperative hemoadsorption during...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doukas, Panagiotis, Hellfritsch, Gabriel, Wendt, Daniel, Magliani, Mirko, Barbati, Mohammad E., Jalaie, Houman, Jacobs, Michael J., Gombert, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866403/ https://www.ncbi.nlm.nih.gov/pubmed/36675474 http://dx.doi.org/10.3390/jcm12020546

Ejemplares similares

The NephroCheck bedside system for detecting stage 3 acute kidney injury after open thoracoabdominal aortic repair
por: Doukas, Panagiotis, et al.
Publicado: (2023)

SLPI - a Biomarker of Acute Kidney Injury after Open and Endovascular Thoracoabdominal Aortic Aneurysm (TAAA) Repair
por: Averdunk, Luisa, et al.
Publicado: (2020)

IFABP levels predict visceral malperfusion in the first hours after open thoracoabdominal aortic repair
por: Doukas, Panagiotis, et al.
Publicado: (2023)

Hemoadsorption by CytoSorb in septic patients: a case series
por: Kogelmann, Klaus, et al.
Publicado: (2017)

Experience with hemoadsorption (CytoSorb(®)) in the management of septic shock patients
por: Mehta, Yatin, et al.
Publicado: (2020)

Pharmacokinetics of anti-infective agents during CytoSorb hemoadsorption
por: Schneider, Antoine G., et al.
Publicado: (2021)

Retrospective observational study evaluating zinc plasma level in patients undergoing thoracoabdominal aortic aneurysm repair and its correlation with outcome
por: Rolles, Benjamin, et al.
Publicado: (2021)

Hemoadsorption in the critically ill—Final results of the International CytoSorb Registry
por: Hawchar, Fatime, et al.
Publicado: (2022)

Onset of Adverse Abdominal Events Due to Intestinal Ischemia-Reperfusion Injury after Aortic Cross-Clamping Is Associated with Elevated HSP70 Serum Levels in the Early Postoperative Phase
por: Doukas, Panagiotis, et al.
Publicado: (2022)

Motor evoked potential-guided segmental artery revascularization during open thoracoabdominal aortic aneurysm surgery after coil embolization as a part of the minimally invasive staged segmental artery coil embolization concept
por: Doukas, Panagiotis, et al.
Publicado: (2022)

Xenogeneic materials for the surgical treatment of aortic infections
por: Keschenau, Paula R., et al.
Publicado: (2021)

Hemoadsorption Using CytoSorb(®) in Patients with Infective Endocarditis: A German-Based Budget Impact Analysis
por: Rao, Cristina, et al.
Publicado: (2023)

Hemoadsorption Treatment with CytoSorb® in Probable Hemophagocytic Lymphohistiocytosis: A Role as Adjunctive Therapy?
por: Ceruti, Samuele, et al.
Publicado: (2021)

Hemoadsorption with CytoSorb(®) and the early course of linezolid plasma concentration during septic shock
por: Köhler, Thomas, et al.
Publicado: (2021)

Cytokine hemoadsorption with CytoSorb® in patients with sepsis: a systematic review and meta-analysis
por: Saldaña-Gastulo, Jiovany Jhan Carlos, et al.
Publicado: (2023)

Recovery of lost motor evoked potentials in open thoracoabdominal aortic aneurysm repair using intercostal artery bypass
por: Gombert, Alexander, et al.
Publicado: (2018)

CytoSorb® Hemoadsorption as a Promising Tool to Handle COVID-19-Induced Cytokine Storm
por: Acevedo, Alice-Christin, et al.
Publicado: (2021)

Hemoadsorption in ‘Liver Indication’—Analysis of 109 Patients’ Data from the CytoSorb International Registry
por: Ocskay, Klementina, et al.
Publicado: (2021)

Sublingual Microcirculatory Evaluation of Extracorporeal Hemoadsorption with CytoSorb® in Abdominal Sepsis: A Case Report
por: Duran, Servet, et al.
Publicado: (2022)

Intraoperative immunomodulation during left heart bypass in open thoracoabdominal aortic aneurysm repair
por: Pascucci, Federico, et al.
Publicado: (2023)

Hemoadsorption of cytokines by CytoSorb filter: a simulation study without human factor—pilot is the difference
por: Nadeem, Rashid, et al.
Publicado: (2020)

Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? Authors' response
por: Supady, Alexander, et al.
Publicado: (2021)

Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb(®)—Basics, Indications and Perspectives—A Scoping Review
por: Köhler, Thomas, et al.
Publicado: (2021)

Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient
por: Alarie, Marianne, et al.
Publicado: (2022)

Cytokine hemoadsorption with CytoSorb(®) in post-cardiac arrest syndrome, a pilot randomized controlled trial
por: Monard, Céline, et al.
Publicado: (2023)

Intraoperative hemoadsorption in high-risk patients with infective endocarditis
por: Haidari, Zaki, et al.
Publicado: (2022)

Open Treatments for Thoracoabdominal Aortic Aneurysm Repair
por: Tanaka, Akiko, et al.
Publicado: (2023)

Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
por: Köhler, Thomas, et al.
Publicado: (2021)

Prevalence and outcome of abdominal vascular injury in severe trauma patients based on a TraumaRegister DGU international registry analysis
por: Barbati, Mohammad Esmaeil, et al.
Publicado: (2021)

The Role of Ribonuclease 1 and Ribonuclease Inhibitor 1 in Acute Kidney Injury after Open and Endovascular Thoracoabdominal Aortic Aneurysm Repair
por: Zechendorf, Elisabeth, et al.
Publicado: (2020)

Case report: Keeping a cool head - A delayed open repair of a ruptured TAAA
por: Doukas, Panagiotis, et al.
Publicado: (2020)

Reply: Does adjunctive hemoadsorption with CytoSorb® affect survival of COVID-19 patients on ECMO? A critical statement
por: Putzu, Alessandro, et al.
Publicado: (2021)

Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry
por: Hayanga, J. W. Awori, et al.
Publicado: (2023)

Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption
por: De Schryver, Nicolas, et al.
Publicado: (2019)

Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective ‘Genetic’ Matched Analysis
por: Rugg, Christopher, et al.
Publicado: (2020)

Rapid reduction of substantially increased myoglobin and creatine kinase levels using a hemoadsorption device (CytoSorb(®))—A case report
por: Moresco, Erich, et al.
Publicado: (2022)

Mortality and adverse events of hemoadsorption with CytoSorb® in critically ill patients: A systematic review and meta‐analysis of randomized controlled trials
por: Heymann, Marc, et al.
Publicado: (2022)

Use of CytoSorb© Hemoadsorption in Patients on Veno-Venous ECMO Support for Severe Acute Respiratory Distress Syndrome: A Systematic Review
por: Akil, Ali, et al.
Publicado: (2022)

Comment on: Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO: the CytoSorb therapy in COVID‑19 (CTC) registry
por: Supady, A., et al.
Publicado: (2023)

Intraoperative ticagrelor removal via hemoadsorption during on-pump coronary artery bypass grafting
por: Hassan, Kambiz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i7k6775t7s4745mg4bbnhdkg0f